Overview

The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study

Status:
Completed
Trial end date:
2018-06-22
Target enrollment:
Participant gender:
Summary
ENRGISE Pilot Study will test the ability of anti-inflammatory interventions for preventing major mobility disability by improving or preserving walking ability.
Phase:
Phase 2
Details
Lead Sponsor:
University of Florida
Collaborators:
Abbott
National Institute on Aging (NIA)
Treatments:
Losartan